Skip to main
CME
CME logo

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 35 analyst ratings
Hold
Strong Buy 17%
Buy 23%
Hold 43%
Sell 9%
Strong Sell 9%

Bulls say

CME Group has demonstrated strong financial growth, underscored by a quarterly dividend increase of approximately 9% year-over-year, marking 14 consecutive years of dividend growth, which reflects robust free cash flow generation. The company has experienced significant advancements in trading volumes, particularly in sectors such as Henry Hub Natural Gas, Micro E-mini futures, and cryptocurrency, with notable increases in average daily volume (ADV) that translate to a revenue generation of around $254 million over the past five years. Additionally, CME Group's strategic acquisitions and continued product innovation have positioned the firm to support ongoing customer demand, particularly in options trading, further enhancing its growth prospects into 2025.

Bears say

CME Group has faced notable pressures in agricultural commodities, particularly with a decline in average daily volume (ADV) in soybean markets attributed to favorable weather conditions in South America that may result in record production. The potential downside scenario indicates a 10% reduction in estimated FY26 earnings per share (EPS) could lead to significant implications for the stock's valuation, particularly with a P/E multiple of 20x. Furthermore, with market data and information services revenue slightly above estimates, the overall financial outlook remains fragile, as consistent declines in open interest could adversely affect investor sentiment and financial conditions for CME Group.

CME Group (CME) has been analyzed by 35 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 23% recommend Buy, 43% suggest Holding, 9% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 35 analysts, CME Group (CME) has a Hold consensus rating as of Jul 10, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $212.57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $212.57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.